Align Technology (ALGN) came out with quarterly earnings of $2.14 per share, beating the Zacks Consensus Estimate of $1.98 per share. This compares to earnings of $1.82 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 8.08%. A quarter ago, it was expected that this maker of the Invisalign tooth-straightening system would post earnings of $2.18 per share when it actually produced earnings of $2.42, delivering a surprise of 11.01 ...

Q1 2024 Financial Results Align Technology, Inc. April 24, 2024 ©2024 Align Technology Inc. All rights reserved. 1 Q1 2024 Conference Call Details Conference call Speakers: Joe Hogan, President and CEO John Morici, CFO Shirley Stacy, VP, Finance, Investor Relations and Corporate Communications ...

Exhibit 99.1 Align Technology Announces First Quarter 2024 Results Align Technology Zeno Group Madelyn Valente Sarah Johnson (909) 833-5839 (828) 551-4201 mvalente@aligntech.com sarah.johnson@zenogroup.com ALIGN TECHNOLOGY ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS Q1'24 total revenues up 5.8% year-over-year including revenue growth of 3.5% from Clear Aligners and growth of 17.5% from Imaging Systems and CAD/CAM Services • Q1'24 total revenues of $997.4 million, increased 5.8% year-over-year, and dilute ...

Several large-cap MedTech players have already announced first-quarter results. Among them, Abbott Laboratories and Walgreens Boots Alliance topped earnings and sales estimates. However, Neogen lagged both earnings and revenue estimates and grappled with ongoing macroeconomic issues. A similar trend is expected to be reflected in the results of other industry players.Some major industry players like Boston Scientific, Inc. (BSX) , Thermo Fisher Scientific, Inc. (TMO) , Align Technology, Inc. (ALGN) and ICON ...

Align Technology, Inc. (ALGN) is set to release first-quarter 2024 results on Apr 24 after the closing bell.The company posted adjusted earnings per share (EPS) of $2.42 in the last reported quarter, which topped the Zacks Consensus Estimate by 11%. Align Technology beat earnings estimates in three of the trailing four quarters and missed in one, the average negative surprise being 5.82%.Let’s look at how things have shaped up before this announcement.Factors at PlayClear Aligner BusinessSimilar to the last ...

Align Technology‘s (ALGN) shares have surged 20.5% year to date compared with the industry’s growth of 6.2%. The Medical sector has gained 3% in the said time frame. The company has a market capitalization of $24.80 billion.This Zacks Rank #2 (Buy) stock is well-positioned to drive the digital revolution in the dental industry with Invisalign clear aligners, Itero Scanners and the Align digital platform. Its earnings are expected to grow 14.2% in the next year.Will the Upside Continue?The consensus estimate ...

Align Technologies (ALGN) recently announced that the Invisalign Palatal Expander system is now commercially available in Australia and New Zealand. The system has been included in the Australian Register of Therapeutic Goods and the New Zealand Web-Assisted Notification of Devices Database and covers broad patient applicability, including growing children, teens and adults (with surgery or other techniques).The newest development is expected to significantly boost ALGN’s Clear Aligner segment. Following it ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Align Technology (ALGN) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.Align Technology is a member of our Medical group, which includes 1054 different companies and currently sits at #4 in the Zacks Sector Rank. The Zacks Sector Rank gauges the str ...

Align Technology’s (ALGN) robust product line, balanced growth across all channels and consistent focus on international markets to drive growth to bolster our confidence in the stock. Yet, we are concerned about the current economic uncertainty that continues to cast a negative impact on Align Technology’s dental procedures. The stock carries a Zacks Rank #3 (Hold).Align Technology is strategically capturing the growing malocclusion market, one of the most prevalent clinical dental conditions in the world. ...

It has been about a month since the last earnings report for Align Technology (ALGN) . Shares have added about 10.6% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Align Technology due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts. Align Technology Tops Q4 Earnings, ...